Methadone Anesthesia For Kidney Transplant Receptors
Unknown statusPhase 3NCT04908345
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Intraoperative methadone or fentanyl will be administered to patients submitted to kidney transplant surgery. Postoperative pain, analgesic consumption and side effects will be evaluated
Study details
- Official title
- Intraoperative Use Of Methadone In The Prevention of Postoperative Pain in Kidney Transplant Receptors
- Conditions
- Renal Failure Chronic
- Surgery
- Interventions
- Sponsor
- University of Sao Paulo General Hospital
- Start date
- 2021-05-17
- Primary completion
- 2022-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients over 18 years of age * With indication for kidney transplant surgery * Who sign the informed consent form Exclusion Criteria: * Patients who refuse to participate in the study * Known allergy to any drug used in this protocol * Presence of stage III or IV congestive heart failure * Increase in QT interval on electrocardiogram (QT\> 500 msec) * Preemptive kidney transplantation (defined by transplantation in a patient who has not yet started kidney replacement therapy).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04908345